+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Postbiotics Market - Global Forecast 2025-2032

  • PDF Icon

    Report

  • 188 Pages
  • November 2025
  • Region: Global
  • 360iResearch™
  • ID: 5924776
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The postbiotics market is progressing rapidly, driven by regulatory shifts and technological innovation that require senior leaders to address emerging compliance obligations and leverage new operational efficiencies. For organizations seeking to maintain a competitive edge, aligning processes and supply chain strategies to meet evolving standards is increasingly critical.

Market Snapshot: Postbiotics Market

In 2024, the postbiotics market reached USD 155.42 million, with projections indicating growth to USD 166.54 million by 2025 and USD 279.55 million by 2032, reflecting a compound annual growth rate (CAGR) of 7.61%.

This upward trajectory is supported by steady advancements in scientific understanding and the ongoing clarification of regulatory frameworks. Businesses serving both the human and animal health sectors are integrating novel encapsulation techniques and stabilization technologies to ensure product safety and maximize efficacy. Variations in regional regulations prompt flexible manufacturing responses, specialized packaging, and tailored logistics solutions—all of which are central to keeping organizations both compliant and market-ready. Senior decision-makers increasingly prioritize investment in clinical research and digital tracking tools, enhancing transparency and reliability across partnership networks.

Scope & Segmentation

  • Product Types: Includes bacterial lysates, enzymes, exopolysaccharides, lipoteichoic acids, peptidoglycan fragments, specialized metabolites like bacteriocins and organic acids, short-chain fatty acids, and vitamins to address wide-ranging nutritional, therapeutic, and functional market needs.
  • Form: Features both dry products, such as capsules, powders, and tablets, and liquid alternatives for adaptable production and varied user preferences.
  • Source: Relies chiefly on ingredients from bacteria and yeast, chosen to support quality control and supply chain stability.
  • Formulation: Offers both encapsulated and unencapsulated variants, simplifying product adaptation for regulatory and sector-specific demands.
  • Processing Methods: Employs chemical treatment, enzymatic hydrolysis, freeze drying, spray drying, irradiation, high-pressure processing, and ultrasonication, facilitating reliable, scalable production.
  • Packaging Type: Utilizes bottles, sachets, and stick packs, engineered for robust logistics and compliance with diverse regulatory regimes to aid efficient market access.
  • Application Areas: Encompasses animal nutrition, human nutrition, food and beverages, pharmaceuticals, cosmetics, and personal care, serving as supplements or active components in product innovation.
  • End User Segments: Develops products for adults, children, and seniors, enabling tailored health and wellness outcomes across demographic profiles.
  • Distribution Channels: Leverages specialty stores, supermarkets, pharmacies, online platforms, and dedicated eCommerce to maximize reach and support omnichannel strategies.
  • Regions Covered: Addresses markets across the Americas, Europe, Middle East and Africa, and Asia-Pacific, each with unique compliance and consumer expectations, necessitating regional go-to-market strategies.
  • Companies Analyzed: Includes industry leaders such as Archer Daniels Midland Company, BASF SE, Cargill Incorporated, DSM-Firmenich AG, Kerry Group plc, and Lallemand Inc., recognized for innovation and technical excellence.

Key Takeaways: Strategic Insights for Senior Leaders

  • Improved standardization of bioactive ingredient quality supports regulatory alignment and helps both established organizations and newcomers ensure consistent product excellence.
  • Deployment of advanced analytics and modular manufacturing systems helps businesses remain agile amid shifting regulatory expectations and dynamic customer needs.
  • Investment in sophisticated traceability and transparent supply chains is establishing dependability and reinforcing trust among partners and clients.
  • Adoption of cutting-edge encapsulation and inventory management technologies enhances the ability to respond to compliance pressures and rapid market shifts.
  • Customization of product formulations to accommodate local requirements and user segments supports differentiation and maintains market relevance globally.
  • Collaboration across supply chain partners promotes operational visibility and enables rapid adaptation to new industry guidelines, further reinforcing organizational confidence.

Tariff Impact

Changing tariff structures in the United States have led manufacturers to diversify supply partnerships, focus on localized operations where feasible, and optimize packaging protocols. Proactive engagement with customs officials, together with improved warehousing practices, enables companies to address evolving trade environments and preserve high service levels.

Methodology & Data Sources

This report is underpinned by direct interviews with sector experts, comprehensive analysis of technical documents, and close monitoring of key regulatory developments. Insights were shaped by consulting engineers, compliance managers, and logistics professionals, ensuring findings are both relevant and applicable for industry leaders.

Why This Report Matters

  • Empowers organizations to align operational and innovation strategies with current regulatory requirements, promoting sustainable relevance in the postbiotics market.
  • Delivers actionable market and partnership benchmarks to inform executive decisions and investment planning.
  • Helps senior management identify and mitigate potential compliance and supply chain vulnerabilities, fostering resilient growth trajectories.

Conclusion

Emphasizing reliable validation, flexible operations, and adaptive compliance strategies positions organizations to navigate market shifts, sustain competitiveness, and pursue secure growth in the evolving postbiotics field.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Rising incorporation of postbiotics in functional foods and beverages
5.2. Emerging consumer preference for natural and sustainable postbiotic products
5.3. Synergistic effects of postbiotics combined with prebiotics and probiotics in supplements
5.4. Development of targeted postbiotic therapies for chronic inflammatory diseases
5.5. Collaborations between biotech firms and food companies accelerating postbiotic innovation
5.6. Influence of regulatory frameworks on postbiotic product development
5.7. Expansion of postbiotic applications in skincare and dermatology sectors
5.8. Increased research highlighting postbiotics' role in immune system support
5.9. Growth in personalized nutrition driving demand for postbiotic supplements
5.10. Advancements in postbiotic formulations enhancing gut health benefits
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Postbiotics Market, by Product Type
8.1. Bacterial Lysates
8.2. Enzymes
8.3. Exopolysaccharides
8.4. Lipoteichoic Acids
8.5. Metabolites
8.5.1. Bacteriocins
8.5.2. Organic Acids
8.5.3. Short-Chain Fatty Acids
8.5.4. Vitamins
8.6. Peptidoglycan Fragments
9. Postbiotics Market, by Form
9.1. Dry
9.1.1. Capsules
9.1.2. Powder
9.1.3. Tablets
9.2. Liquid
10. Postbiotics Market, by Source
10.1. Bacterial Derived
10.2. Yeast Derived
11. Postbiotics Market, by Formulation
11.1. Encapsulated
11.2. Unencapsulated
12. Postbiotics Market, by Processing Method
12.1. Chemical Treatment
12.2. Enzymatic Hydrolysis
12.3. Freeze Drying
12.4. High-Pressure Processing
12.5. Irradiation
12.6. Spray Drying
12.7. Ultrasonication
13. Postbiotics Market, by Packaging Type
13.1. Bottles
13.2. Sachets
13.3. Stick Packs
14. Postbiotics Market, by Application
14.1. Animal Nutrition
14.1.1. Aquaculture Feed
14.1.2. Livestock Feed
14.1.3. Pet Food & Treats
14.2. Cosmetics & Personal Care
14.2.1. Hair Care
14.2.2. Oral Care
14.2.3. Skin Care
14.3. Food & Beverages
14.3.1. Beverages
14.3.2. Dairy & Dairy Alternatives
14.3.3. Functional Food
14.3.4. Infant Formula
14.4. Human Nutrition
14.5. Pharmaceuticals
15. Postbiotics Market, by End User
15.1. Adults
15.2. Geriatrics
15.3. Pediatrics
16. Postbiotics Market, by Distribution Channel
16.1. Offline
16.1.1. Pharmacies & Drug Stores
16.1.2. Specialty Stores
16.1.3. Supermarkets & Hypermarkets
16.2. Online
16.2.1. Brand Websites
16.2.2. eCommerce Platforms
17. Postbiotics Market, by Region
17.1. Americas
17.1.1. North America
17.1.2. Latin America
17.2. Europe, Middle East & Africa
17.2.1. Europe
17.2.2. Middle East
17.2.3. Africa
17.3. Asia-Pacific
18. Postbiotics Market, by Group
18.1. ASEAN
18.2. GCC
18.3. European Union
18.4. BRICS
18.5. G7
18.6. NATO
19. Postbiotics Market, by Country
19.1. United States
19.2. Canada
19.3. Mexico
19.4. Brazil
19.5. United Kingdom
19.6. Germany
19.7. France
19.8. Russia
19.9. Italy
19.10. Spain
19.11. China
19.12. India
19.13. Japan
19.14. Australia
19.15. South Korea
20. Competitive Landscape
20.1. Market Share Analysis, 2024
20.2. FPNV Positioning Matrix, 2024
20.3. Competitive Analysis
20.3.1. Archer Daniels Midland Company
20.3.2. BASF SE
20.3.3. Cargill Incorporated
20.3.4. DSM-Firmenich AG
20.3.5. Kerry Group plc
20.3.6. Kirin Holdings Company, Limited.
20.3.7. Mitsubishi Corporation
20.3.8. MRM Nutrition
20.3.9. Lesaffre group
20.3.10. ABbiotek Health
20.3.11. Novonesis Group
20.3.12. International Flavors & Fragrances Inc.

Companies Mentioned

The companies profiled in this Postbiotics market report include:
  • Archer Daniels Midland Company
  • BASF SE
  • Beekeeper's Naturals, Inc.
  • Bioflag Co., Ltd. by AUSNUTRIA DAIRY CORPORATION LTD
  • Cargill Incorporated
  • Dr Emil Nutrition
  • DSM-Firmenich AG
  • Essential Formulas Incorporated
  • GeneFerm Biotechnology Co., Ltd.
  • Glac Biotech Co., Ltd.
  • GutArmor by Get Wellness, LLC
  • Healist Naturals, LLC
  • ILDONG BIOSCIENCE CO.,LTD.
  • Kemin Industries, Inc.
  • Kerry Group PLC
  • Kirin Holdings Company, Limited.
  • Maypro Group
  • Mitsubishi Corporation
  • MRM Nutrition
  • Lesaffre group
  • ​POSTBIOTICA S.R.L.
  • Probioway Co., Ltd.
  • Postbiotics Inc.
  • Sabinsa Corporation
  • Silab SA
  • woresan GmbH
  • ABbiotek Health
  • Novonesis Group
  • International Flavors & Fragrances Inc.
  • MORINAGA MILK INDUSTRY CO.,LTD.
  • Lallemand Inc

Table Information